Regulatory PathRegulatory requirements compared

Active substances

Citric acid + Magnesium oxide + Sodium picosulfate

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
PICOPREP POWDER FOR ORAL SOLUTION12,3.5,10 g,g,mgPowder for oral solution · Oral use2 SachetSAR 26.75NCE · PrescriptionFERRINGValid

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CLENPIQ12GM/BOT;3.5GM/BOT;10MG/BOTsolution · oralFERRING PHARMS INCPrescription28 Nov 2017
SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID12GM/PACKET;3.5GM/PACKET;10MG/PACKETfor solution · oralHETERO LABS LTD VPrescription18 Jul 2022
PREPOPIK12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**for solution · oralFERRING PHARMS INCDiscontinued16 Jul 2012

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
PICO-SALAX0225479412 G / SACHET; 3.5 G / SACHET; 10 MG / SACHETPOWDER FOR SOLUTION · ORALFERRING INC
PURG-ODAN0231796612 G / SACHET; 10 MG / SACHET; 3.5 G / SACHETPOWDER FOR SOLUTION · ORALODAN LABORATORIESLTD

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACCLENPIQ 175 ML SOLUTION$0.51785per ML23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.